Cambridge Spinout Broken String Biosciences Raises $15M To Make Cell And Gene Therapies Safer And Affordable
Cambridge Spinout Broken String Biosciences Raises $15M To Make Cell And Gene Therapies Safer And Affordable
09/18/23, 9:30 AM
Location
cambridgeMoney raised
$15 million
Industry
biotechnology
Investors
Arnaud Autret, Yoann Bonnamour, Dieter Von Holtzbrinck Ventures, Tencent, Heran Partners, Mérieux Equity Partners, Illumina Ventures
Now, Broken String Biosciences has picked up $15 million in Series A funding. The investment round was co-led by Illumina Ventures, which recently backed Lightcast Discovery and Mérieux Equity Partners, with contributions from HERAN Partners, and existing investors Tencent and Dieter von Holtzbrinck Ventures (DvH Ventures). As part of the round, Yoann Bonnamour, Mérieux Equity Partners, and Arnaud Autret, Illumina Ventures, join the company’s Board of Directors.